Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
Trends in Parasitology|May 19, 2006
Progress towards the development of malaria vaccinesElissa Malkin, Filip Dubovsky, Melinda Moree
The Journal of the American Board of Family Practice|June 1, 2002
Pseudotumor cerebri secondary to minocycline intakeEarl Robert G Ang, J C Chava Zimmerman, Elissa Malkin
The Pediatric Infectious Disease Journal|September 20, 2011
Phase 1 study of the safety and immunogenicity of a live, attenuated respiratory syncytial virus and parainfluenza virus type 3 vaccine in seronegative childrenDavid I Bernstein, Elissa Malkin, Nazha Abughali, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 23, 2008
Ex vivo cytokine and memory T cell responses to the 42-kDa fragment of Plasmodium falciparum merozoite surface protein-1 in vaccinated volunteersMaria Cecilia Huaman, Laura B Martin, Elissa Malkin, et al.
The Journal of Infectious Diseases|May 13, 2009
Quantitative detection of Plasmodium falciparum DNA in saliva, blood, and urineDavis C Nwakanma, Natalia Gomez-Escobar, Michael Walther, et al.
Plos One|November 10, 2010
Safety and immunogenicity following administration of a live, attenuated monovalent 2009 H1N1 influenza vaccine to children and adults in two randomized controlled trialsRaburn M Mallory, Elissa Malkin, Christopher S Ambrose, et al.
Vaccine|April 23, 2013
Implication of respiratory syncytial virus (RSV) F transgene sequence heterogeneity observed in Phase 1 evaluation of MEDI-534, a live attenuated parainfluenza type 3 vectored RSV vaccineChin-Fen Yang, C Kathy Wang, Elissa Malkin, et al.
Expert Review of Vaccines|September 24, 2013
Translational sciences approach to RSV vaccine developmentVanessa Kurzweil, Roderick Tang, Mark Galinski, et al.
Plos One|November 9, 2013
Safety and immunogenicity of a live attenuated RSV vaccine in healthy RSV-seronegative children 5 to 24 months of ageElissa Malkin, Ram Yogev, Nazha Abughali, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 4, 2008
Comparison of biological activity of human anti-apical membrane antigen-1 antibodies induced by natural infection and vaccinationKazutoyo Miura, Hong Zhou, Samuel E Moretz, et al.
Pageof 3